CSI Market
Sign In | Register

Spyglass Pharma Inc (SGP) Annual Balance Sheets

Annual · GAAP · USD millions
Access SGP quarterly Balance Sheets →
The data below summarizes Spyglass Pharma Inc's balance sheet position from FY 2005 to Dec 31 2025, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(FY 2008) (FY 2007) (FY 2006) (FY 2005)
Assets
Cash & cash equivalent96.36
Short-term investments0.00
Cash & Short-term Investments96.00
Accounts receivable0.00
Other Receivables, Net, Current0.43
Inventories0.00
Other current assets11.08
Income Taxes0.00
Prepaid Expense And Other Assets Current0.90
Total Current Assets108.77
Equipment/Property/Plant Net2.34
Goodwill net0.00
Intangible Assets0.00
Other Assets4.76
Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss Current11.08
Total Assets115.87
Liabilities
Accounts Payable, Current AC2.70
Employee-related Liabilities, Current AC2.18
Shortterm debt0.00
Other current liabilities3.71
Income & other taxes0.00
Total Current Liabilities8.58
Long-term debt0.00
Total Long-term Debt0.00
Deferred income taxes0.00
Other longterm liabilities1.58
OperatingLeaseLiabilityNoncurrent1.58
Total Liabilities10.17
Stockholders' Equity
Additional Paid In Capital Common Stock5.89
Retained Earnings / Accumulated Deficit-104.73
Other Equity-204.54
Common Stockholder's Equity-303.37
Non-controlling interests & other204.54
Total Stockholder's Equity-98.84
Liabilities & Stockholder's Equity115.87
4 historic quarters locked

Sign in to unlock the full Spyglass Pharma Inc balance sheet history.

Sign In Create Free Account

About Spyglass Pharma Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 26, 2026
  • Source: sgp-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001778922-26-000020

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.